These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24348845)

  • 1. microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells.
    Li H; Xu H; Shen H; Li H
    Oncol Lett; 2014 Jan; 7(1):183-188. PubMed ID: 24348845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3.
    Wu H; Xiao Z; Zhang H; Wang K; Liu W; Hao Q
    Anticancer Drugs; 2014 Aug; 25(7):799-809. PubMed ID: 24686007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.
    Rao YM; Shi HR; Ji M; Chen CH
    J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):567-572. PubMed ID: 23904379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.
    Tian J; Xu YY; Li L; Hao Q
    Am J Transl Res; 2017; 9(3):1127-1138. PubMed ID: 28386339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
    Wang X; Zhu J
    Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells.
    Lou Y; Cui Z; Wang F; Yang X; Qian J
    Clin Invest Med; 2011 Oct; 34(5):E281. PubMed ID: 21968270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on the inhibition effect of miR-106a inhibitor on tumor growth of ovarian cancer xenografts mice.
    Cai ZH; Chen LM; Liang YJ; Shi JR; You-Ju MA; Wang WM; Yang H
    Asian Pac J Trop Med; 2016 Jul; 9(7):698-701. PubMed ID: 27393101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4.
    Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K
    Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of microRNA-21 in the proliferation and apoptosis of ovarian epithelial carcinoma cells].
    Lou YH; Cui ZM; Wang FL; Yang XS
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):684-9. PubMed ID: 22176994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
    Zhang H; Lu J; Jiang C; Lu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
    Huh JH; Kim TH; Kim K; Song JA; Jung YJ; Jeong JY; Lee MJ; Kim YK; Lee DH; An HJ
    Br J Cancer; 2013 Jul; 109(2):452-61. PubMed ID: 23807165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis.
    Fu X; He Y; Wang X; Peng D; Chen X; Li X; Wang Q
    Stem Cell Res Ther; 2017 Aug; 8(1):187. PubMed ID: 28807003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.
    Yang L; Li N; Wang H; Jia X; Wang X; Luo J
    Oncol Rep; 2012 Aug; 28(2):592-600. PubMed ID: 22614869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.